Abstract Insulin promotes protein accretion in cardiac and skeletal muscles through a stimulation of the mRNA translation initiation phase of protein synthesis. The present set of experiments examined the regulatory TSC2 signaling pathway that potentially contributes to the myocardial responsiveness of protein synthesis to insulin in postabsorptive male Sprague-Dawley rats in vivo. Heart and skeletal muscles were sampled from rats up to 1 h following intravenous injection of various doses of insulin. In cardiac muscle, TSC2 phosphorylation was elevated only at the highest plasma insulin concentration (386 ng/ml). In contrast, the extent of mTOR phosphorylation either on Ser (2448) or Ser (2481) was raised at 24-fold less concentration of insulin and corresponded with increased phosphorylation of PKB(Thr 308 ) or PKB(Ser 473 ). In gastrocnemius, TSC2 phosphorylation was elevated at plasma insulin concentrations (16 ng/ml) lower than that observed in cardiac muscle (386 ng insulin/ml). The increased TSC2 phosphorylation corresponded with a marked stimulation of PKB phosphorylation. However, mTOR(Ser 2448 ) or mTOR(Ser 2481 ) phosphorylation was not elevated until the plasma insulin concentration reached 97 ng/ml. The results indicate there is a dissociation of TSC2 and mTOR phosphorylation in vivo.
Introduction
Insulin enhances protein synthesis short term via acceleration of mRNA translation initiation and long term through stimulation of RNA biogenesis and transcription. An acute rise in plasma insulin concentrations activates the PI3-kinase-PKB signal pathway leading to enhanced mammalian Target of Rapamycin (mTOR) phosphorylation. mTOR itself does not directly affect the translation machinery but instead prompts subsequent phosphorylation of S6K1 and 4E-BP1, both regulators of mRNA translation initiation [1, 2] .
Several signaling pathways potentially modulate mTOR activity including the tumor suppressor complex (TSC). TSC consists of the gene products associated with the complex, namely hamartin (TSC1) and tuberin (TSC2) [3, 4] . It has been hypothesized that hamartin and tuberin are responsible for the activity of the TSC and function together in the complex to inhibit mTOR-mediated signaling to 4E-BP1 and S6K1 in transformed cells in culture [3] . TSC2 lacks a kinase domain and as such regulates mTOR through indirect mechanisms. Tuberin has a GTPase-activating protein (GAP) domain toward the Ras family small GTPase called Rheb (RAS homolog enriched in brain) [3, [5] [6] [7] . Rheb stimulates the phosphorylation of mTOR on Ser 2448 in response to stimuli known to enhance mTOR activity, including activation of PKB [6] . Tuberindependent stimulation of GTP hydrolysis of Rheb blocks phosphorylation of mTOR (Ser 2448 ), which antagonizes the mTOR-signaling pathway.
The activity of TSC is regulated through phosphorylation. In vitro studies indicate that TSC2 phosphorylation appears dependent upon the PI3K/PKB signaling pathway whereby activated PKB phosphorylates tuberin at residue Thr 1462 [6, 8, 9] . Hence, phosphorylation of Thr 1462 on TSC2 limits the tuberin/hamartin complex reductions of Rheb-GTPase activity, thereby relieving inhibition mTOR. We previously reported that neither IGF-I [10] nor meal feeding [11, 12] affects phosphorylation of Thr 1462 on TSC2 in heart or skeletal muscle. Insulin is a potent activator of PKB. In the present set of investigations we tested the hypothesis that insulin, which is known to stimulate the phosphorylation of mTOR, acts through a PKB-dependent pathway to stimulate TSC2 and thereby enhances phosphorylation of mTOR. Therefore, we tested the hypothesis that insulin could enhance phosphorylation of Thr 1462 on TSC2. We further examined whether or not the response was the same in skeletal muscle and cardiac muscle. We are able to demonstrate a differential sensitivity to stimulation of phosphorylation of Thr 1462 on TSC2 in skeletal muscle and heart.
Methods
Pathogen-free male Sprague-Dawley rats were purchased from Charles River Laboratories (Cambridge, MA) and maintained at our facility for at least 7 days prior to the experiment. All animals were fed and provided water ad libitum. The Institutional Animal Care and Use Committee approved the animal protocols and adhered to National Institute of Health guidelines for the use of experimental animals. Rats (300-350 g) were anesthetized (Nembutal 50 mg/100 body wt) after which a midline incision was performed and the inferior vena cava exposed.
Experiment 1
In these investigations various doses of insulin (0.01-10 units/100 gm body wt) (NPH Ilentin II, E. Lilly and Co., Indianapolis, IN) or an equivalent volume of saline (0.9% NaCl) (Basal) was injected into the inferior vena cava. Blood for measurement of plasma insulin concentrations was withdrawn after 20 min, and the gastrocnemius and heart were excised and immediately frozen between clamps precooled to the temperature of liquid nitrogen.
Experiment 2
In another set of experiments, the time dependency for effects of insulin was established. At various times (5, 20, 40 , and 60 min) following injection of insulin (10 unit/ml) into the inferior vena, the gastrocnemius and heart was excised and immediately frozen between clamps precooled to the temperature of liquid nitrogen as described for Experiment 1.
Frozen heart and gastrocnemius from either Experiment 1 or Experiment 2 were powdered under liquid nitrogen using a mortar and pestle, and the powdered tissue was stored at -85°C until extraction. Extraction of the frozen powdered gastrocnemius and heart was accomplished by homogenizing in 7 volumes of buffer A (20 mM HEPES, pH 7.4, 100 mM KCl, 0.2 mM EDTA, 2 mM EGTA, 1 mM DTT, 50 mM NaF, 50 mM b-glycerolphosphate, 0.1 mM PMSF, 1 mM benzamidine, 0.5 mM sodium vanadate, and 1 lM microcystin LR) using a Polytron homogenizer. The homogenate was centrifuged at 10,000 9 g for 10 min at 4°C and the pellet was discarded. An aliquot of the 10,000 9 g supernatant was mixed with an equal volume of 29 Laemmli sodium dodecyl sulfate (SDS) sample buffer (65°C). Another aliquot was used to measure the protein concentration by the Biuret method with crystalline bovine serum albumin serving as a standard. Equal amounts of protein from homogenate supernatant were electrophoresed and transferred to PVDF membranes as described previously [10] [11] [12] .
Determination of phosphorylation of PKB, GSK3, eEF2, and TSC2
The membranes were then incubated with phospho-specific antibodies that recognize the phospho-PKB(Thr ) (Cell Signaling Technology, Beverly, MA). The autoradiographs were developed and analyzed as described previously [10] [11] [12] . The membranes were then immunoblotted with the antibody that recognizes PKB (Cell Signaling Technology, Beverly, MA), GSK3 (Biosource International, Camarillo, CA), eEF2, or TSC2 (Cell Signaling Technology, Beverly, MA) independently of its phosphorylation state. The phosphorylated PKB or TSC2 signal densities were normalized to the respective total PKB or TSC2 signal to reflect the relative ratio of phosphorylated PKB or TSC2 to total PKB or TSC2, respectively.
Determination of phosphorylation of mTOR
An equal amount of protein from the homogenate supernatant was separated by 5% SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to PVDF membranes. The PVDF membranes were then incubated with either an antibody that recognizes the phosphorylated form of mTOR(Ser 2448 ) or one that recognizes mTOR(Ser 2481 ) (Cell Signaling Technology, Beverly, MA). The autoradiographs were developed and analyzed as described previously [10] [11] [12] . The membranes were subsequently immunoblotted with the antibodies that recognizes mTOR independently of its phosphorylation state (Bethyl Laboratories, Inc., Montgomery, TX) and analyzed. The phosphorylated mTOR signal densities were normalized to the respective total mTOR signal to reflect the relative ratio of phosphorylated mTOR to total mTOR.
Statistics
Values are presented as means ± standard error of the mean (SEM) of multiple densitometric analyses for each group. Results were compared using ANOVA statistical analysis followed by the Sidak test when ANOVA indicated a significant difference (P \ 0.05). Differences were considered significant when P \ 0.05.
Results

Heart
The activity of TSC is regulated through phosphorylation. Figure 1 illustrates the changes in the extent of TSC2(Thr 1462 ) phosphorylation in cardiac muscle 20 min following a single bolus injection of various amounts of insulin. Insulin concentration in the post-absorptive condition (Basal) averaged 2 ± 0.4 ng/ml. Raising the plasma concentration by eightfold (16 ± 2 ng/ml) or 42-fold (97 ± 10 ng/ml) above basal did not significantly increase the extent of TSC2(Thr 1462 ) phosphorylation. Raising the plasma insulin concentration to 386 ng/ml following a supraphysiological bolus injection of insulin elevated the extent of TSC2(Thr 1462 ) phosphorylation twofold compared with basal (2 ng/ml insulin).
TSC2 phosphorylation depends in part on the PI3K/PKB signaling pathway whereby activated PKB phosphorylates tuberin at residue Thr 1462 in transformed cells in culture [6, 8, 9] . In the present set of studies, we examined the phosphorylation of PKB following administration of insulin. We also examined the phosphorylation state of three other proteins whose activity is regulated by insulin-mediated signaling cascades. The extent of GSK3a and GSK3b phosphorylation was significantly elevated 120% and 460%, respectively (Table 1) . In contrast to other proteins examined, raising the insulin concentration decreases the phosphorylation of elongation factor (EF) 2. eEF2 phosphorylation was lowered by 35% following injection of insulin compared with basal values (Table 1) . Thus, the failure to increase TSC2(Thr 1462 ) phosphorylation following raising the plasma insulin concentration to either 16 or 97 ng/ml was not the result of an inability of insulin to activate its signaling pathways.
The aforementioned changes in the extent of TSC2 phosphorylation following administration of insulin might be expected to modulate phosphorylation of mTOR. Therefore, we examined the phosphorylation state of Ser 2448 and Ser 2481 following insulin administration in cardiac muscle (Fig. 3 top and bottom panels) . Raising the plasma insulin concentration to 16 ng/ml resulted in an over twofold increase in the extent of mTOR phosphorylation on both Ser 2448 and Ser 2481 . The insulin-induced elevation in phosphorylation of mTOR on both Ser 2448 and Ser 2481 was maintained as the plasma insulin concentration was further raised.
We also investigated the time course for insulin to activate the various signaling cascades. In these studies, the plasma insulin concentration was raised to 386 ± 35 ng/ml. The elevation in the extent of TSC2 phosphorylation occurred within 5 min of raising the insulin concentration compared with T 0 measurements (Fig. 4) . The extent of phosphorylation continued to rise over the course of the experimental period (60 min). Likewise, we also examined the phosphorylation of PKB at various times following a bolus injection of insulin. The time course showed significant elevation in the extent phosphorylation of PKB on either Thr 308 or Ser 473 within 5 min and remained significantly elevated for up to 60 min after insulin administration (Fig. 5) . As was observed with TSC2 and PKB, phosphorylation of mTOR (Ser 2448 ) was significantly increased 100% relative to T 0 after 5 min and remained elevated for at least 60 min (Fig. 6 top panel) . Phosphorylation of mTOR(-Ser 2481 ) also showed a similar pattern as phosphorylation of mTOR(Ser 2448 ) (Fig. 6 bottom panel) .
Skeletal muscle
In skeletal muscle a different sensitivity to the ability of insulin to effect an increase in phosphorylation of TSC2 was observed compared with that observed in heart. The extent of TSC2 phosphorylation was significantly increased at plasma insulin concentrations as low as 3 ng/ml relative to basal (Fig. 7) . The level of TSC2 phosphorylation remained elevated as the concentration of insulin was further increased. We next examined the phosphorylation of PKB on either Thr 308 or Ser 473 in skeletal muscle following a bolus injection of insulin (Fig. 8) . With low 473 ) was observed when the plasma insulin concentration was raised to 16 ng/ml compared with basal. With higher dose of insulin, the extent of phosphorylation of PKB on either Thr 308 or Ser 473 fell but remained significantly elevated approximately fivefold and threefold, respectively, compared with basal at the highest concentration of insulin (Fig. 8) .
The phosphorylation state of mTOR on Ser 2448 and Ser 2481 following insulin administration in gastrocnemius ( Fig. 9 top and bottom panels) was also investigated. While TSC2 and PKB phosphorylation was elevated at 16 ng/ml insulin, the extent of mTOR phosphorylation on either Ser 2448 or Ser 2481 was only significantly increased when the plasma insulin concentration was raised to 97 ng/ml. The insulininduced elevation in phosphorylation of mTOR on either Ser 2448 or Ser 2481 was maintained as the plasma insulin concentration was further raised. The time course for changes in phosphorylation of TSC2 (Fig. 10) , PKB (Fig. 11) and mTOR(Ser 2448 ) and mTOR(Ser 2481 ) (Fig. 12) were examined next. Unlike cardiac muscle, the extent of TSC2(Thr 1462 ) phosphorylation was elevated approximately eightfold within 5 min of raising the plasma insulin concentration. Subsequently, TSC2 phosphorylation fell compared with T 5 , but remained fourfold elevated compared with basal measurements (time 0) and continued at that level for up to 60 min.
Unlike TSC2, there was a differential response for individual phosphorylation sites on PKB after raising the plasma insulin concentration. PKB phosphorylation on Thr 308 was not significantly altered at any of the time points examined. In contrast, PKB phosphorylation on Ser 473 was elevated within 5 min following injection of insulin but dropped by 20 min to values that were not significantly different from T 0 (Fig. 11) . The extent of phosphorylation remained at that level for periods up to 60 min.
The effect of insulin on the extent of mTOR(Ser 2448 ) and mTOR(Ser 2481 ) showed a selective response following increasing the plasma insulin. mTOR(Ser 2448 ) phosphorylation was elevated within 5 min of raising the plasma insulin concentration and remained elevated for 60 min. In contrast, mTOR(Ser 2481 ) phosphorylation was not elevated within 5 min of raising the plasma insulin concentration. However, mTOR(Ser 2481 ) phosphorylation was elevated by 20 min following increasing plasma insulin concentrations. 
Discussion
Control of translation initiation is an important mechanism, which tightly regulates the skeletal muscle protein accretion and growth, through multiple effector proteins. Coordinated regulation of these processes occurs through activation or inhibition of multiple signaling pathways allowing the skeletal muscle to integrate information regarding mitogenic and nutrient signals. Central to the acute regulation of mRNA translation initiation is mTOR, which assimilates signals from several different inputs. mTOR is reported to be a common intermediate involved in mRNA translation control produced by growth factors (for review see [13] ) by acting as the upstream kinase responsible for phosphorylating 4E-BP1 and S6K1 [14, 15] . Activation of mTOR involves phosphorylation of at least two serine residues, Ser 2448 and Ser 2481 , located in the C-terminal repressor domain. Deletion of this domain renders the mutant constitutively active [16] . Because Ser 2481 phosphorylation does not occur in a kinase-inactive mTOR, this site is considered to be autophosphorylated [17] . As such, rapamycin has no effect on Ser 2481 phosphorylation. In contrast, IGF-I and amino acids induce Ser 2448 phosphorylation [10] [11] [12] [18] [19] [20] , which corresponds with activation of mTOR [21, 22] . Hence, phosphorylation of mTOR on residues Ser 2448 and Ser 2481 has been used to monitor the activity of mTOR [17, 23] . As such, altered mTOR phosphorylation appears to represent an important nexus for the observed changes in translation initiation. One pathway that has been implicated in regulating mTOR involves TSC2. TSC2 is the functional component of the TSC1/2 complex that limits mTOR-signaling. TSC2 appears regulated through phosphorylation via the PI3K/ PKB signaling pathway [8, 9] . Phosphorylation of tuberin by PKB through a PI3K-dependent pathway abrogates the inhibitory hamartin/tuberin activity toward mTOR [6, 24] . Increased phosphorylation of TSC2 is thought to activate mTOR in part through raising the phosphorylation state of mTOR in transformed cells in culture. In heart, we observed a divergence between insulin-induced phosphorylation of TSC2 and the phosphorylation state of mTOR. While phosphorylation of mTOR on residues Ser 2448 and Ser 2481 was raised above basal values at plasma insulin concentrations of 16 ng/ml or greater, the phosphorylation state of TSC2 was only increased when the plasma concentration was elevated to pharmacological levels (386 ng/ ml). Thus, it is unlikely that phosphorylation of TSC2 plays a significant role in the response of mTOR phosphorylation following injection of insulin. The failure of insulin to raise the phosphorylation of TSC2 did not appear related to a defect with insulin signaling per se because both the phosphorylation of PKB and GSK-3 were increased at plasma insulin concentration much lower (16 ng/ml) than those needed to stimulate phosphorylation of TSC2. Therefore, phosphorylation of TSC2 is less sensitive to insulin stimulation than are other insulin dependent signaling pathways.
Moreover, the extent of phosphorylation of mTOR was fully enhanced within 5 min of injection of insulin. In contrast, the extent of phosphorylation of TSC2 continued to increase for periods up to 1 h. Thus as was observed with the concentration dependency curve, there exists a divergence between TSC2 and mTOR phosphorylation. Taken together, these data cast doubts as to the importance of TSC2 in activating myocardial mTOR phosphorylation in vivo. Similar conclusions were reached in heart following injection of IGF-I [10] or feeding rats a diet containing ethanol [25] . In both cases TSC2 phosphorylation remained unaltered despite changes in mTOR phosphorylation.
We compared the sensitivity of TSC2 phosphorylation to insulin administration in skeletal muscle with that in cardiac muscle. TSC2 phosphorylation was elevated at a much lower (16 ng/ml) concentration of insulin in gastrocnemius compared with heart. Likewise, mTOR phosphorylation was increased at a lower concentration (97 ng/ml) of insulin in gastrocnemius compared with cardiac muscle. Elevations in both TSC2 and PKB phosphorylation occurred at concentrations lower than that for mTOR. These observations imply a greater sensitivity to activation of mTOR pathways by insulin in skeletal muscle compared with cardiac muscle. The regulation of mTOR in skeletal muscle appears to be similar to that seen in heart albeit at a lower plasma concentration of insulin, yet the pattern of PKB phosphorylation is markedly different. The results are consistent with in vivo studies showing that protein synthesis in muscles composed primarily of fast twitch fibers such as gastrocnemius are more sensitive to alterations in insulin than cardiac muscle. The reasons for this difference are not presently fully understood.
In summary, the results indicate that the extent of TSC2 phosphorylation following insulin injection does not correspond with phosphorylation of mTOR in heart muscle. Hence, it is doubtful phosphorylation of TSC2 is an important regulator of mTOR under the physiological condition of the post-absorptive state. Furthermore the results suggest that other insulin signaling pathways are responsible for activation of mTOR in post-absorptive state. In this regard, phosphorylation of PKB is associated with the rise in the extent mTOR phosphorylation following insulin administration. Similar conclusions were obtained in skeletal muscle. However, activation of TSC2 and mTOR phosphorylation in skeletal muscle appears more sensitive to stimulatory effects of insulin than cardiac muscle.
